Cargando…

Emergency admission and survival from aggressive non-Hodgkin lymphoma: A report from the UK's population-based Haematological Malignancy Research Network

BACKGROUND: Non-Hodgkin lymphoma (NHL) is often diagnosed after emergency presentation, a route associated with poor survival and an indicator of diagnostic delay. Accounting for around half of all NHLs, diffuse large B-cell lymphoma (DLBCL) is of particular interest since although it is potentially...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kane, Eleanor, Howell, Debra, Smith, Alexandra, Crouch, Simon, Burton, Cathy, Roman, Eve, Patmore, Russell
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Science Ltd 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5446261/ https://www.ncbi.nlm.nih.gov/pubmed/28412589 http://dx.doi.org/10.1016/j.ejca.2017.03.013

Ejemplares similares

Hodgkin lymphoma detection and survival: findings from the Haematological Malignancy Research Network
por: Lamb, Maxine JE, et al.
Publicado: (2019)

Impact of age and socioeconomic status on treatment and survival from aggressive lymphoma: a UK population-based study of diffuse large B-cell lymphoma
por: Smith, Alexandra, et al.
Publicado: (2015)

Impact of novel therapies for mantle cell lymphoma in the real world setting: a report from the UK's Haematological Malignancy Research Network (HMRN)
por: Smith, Alexandra, et al.
Publicado: (2018)

The impact of rheumatological disorders on lymphomas and myeloma: a report on risk and survival from the UK’s population-based Haematological Malignancy Research Network
por: Kane, Eleanor, et al.
Publicado: (2019)

Cohort Profile Update: The Haematological Malignancy Research Network (HMRN) UK population-based cohorts
por: Roman, Eve, et al.
Publicado: (2022)

Cohort Profile: The Haematological Malignancy Research Network (HMRN): a UK population-based patient cohort
por: Smith, Alexandra, et al.
Publicado: (2018)

Preferred and actual place of death in haematological malignancies: a report from the UK haematological malignancy research network
por: Sheridan, Rebecca, et al.
Publicado: (2021)

Lymphoma incidence, survival and prevalence 2004–2014: sub-type analyses from the UK's Haematological Malignancy Research Network
por: Smith, A, et al.
Publicado: (2015)

Incurable but treatable: Understanding, uncertainty and impact in chronic blood cancers—A qualitative study from the UK’s Haematological Malignancy Research Network
por: Howell, Debra A., et al.
Publicado: (2022)

Time-to-diagnosis and symptoms of myeloma, lymphomas and leukaemias: a report from the Haematological Malignancy Research Network
por: Howell, Debra A, et al.
Publicado: (2013)

A Generic Model for Follicular Lymphoma: Predicting Cost, Life Expectancy, and Quality-Adjusted-Life-Year Using UK Population–Based Observational Data()
por: Wang, Han-I, et al.
Publicado: (2018)

Treatment cost and life expectancy of diffuse large B-cell lymphoma (DLBCL): a discrete event simulation model on a UK population-based observational cohort
por: Wang, Han-I., et al.
Publicado: (2016)

‘Unpacking’ pathways to lymphoma and myeloma diagnosis: Do experiences align with the Model of Pathways to Treatment? Findings from a UK qualitative study with patients and relatives
por: Howell, Debra, et al.
Publicado: (2020)

Treatment decision making (TDM): a qualitative study exploring the perspectives of patients with chronic haematological cancers
por: McCaughan, Dorothy, et al.
Publicado: (2022)

Haematology nurses' perspectives of their patients' places of care and death: A UK qualitative interview study
por: McCaughan, Dorothy, et al.
Publicado: (2019)

Myeloid malignancies in the real-world: Occurrence, progression and survival in the UK’s population-based Haematological Malignancy Research Network 2004–15
por: Roman, Eve, et al.
Publicado: (2016)

Place of death in haematological malignancy: variations by disease sub-type and time from diagnosis to death
por: Howell, Debra A, et al.
Publicado: (2013)

Determinants of hospital death in haematological cancers: findings from a qualitative study
por: McCaughan, Dorothy, et al.
Publicado: (2018)

The Haematological Malignancy Research Network (HMRN): a new information strategy for population based epidemiology and health service research
por: Smith, Alexandra, et al.
Publicado: (2010)

Risk of mature B‐cell neoplasms and precursor conditions after joint replacement: A report from the Haematological Malignancy Research Network
por: Kane, Eleanor, et al.
Publicado: (2019)

Molecular subclusters of follicular lymphoma: a report from the United Kingdom’s Haematological Malignancy Research Network
por: Crouch, Simon, et al.
Publicado: (2022)

Experiences and preferences for psychosocial support: a qualitative study exploring the views of patients with chronic haematological cancers
por: Sheridan, Rebecca, et al.
Publicado: (2023)

Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network
por: Smith, A, et al.
Publicado: (2011)

Hodgkin's lymphoma and infection: findings from a UK case–control study
por: Newton, R, et al.
Publicado: (2007)

Destined to die in hospital? Systematic review and meta-analysis of place of death in haematological malignancy
por: Howell, Debra A, et al.
Publicado: (2010)

Palliative care specialists’ perceptions concerning referral of haematology patients to their services: findings from a qualitative study
por: McCaughan, Dorothy, et al.
Publicado: (2018)

Health impact of monoclonal gammopathy of undetermined significance (MGUS) and monoclonal B-cell lymphocytosis (MBL): findings from a UK population-based cohort
por: Lamb, Maxine JE, et al.
Publicado: (2021)

Multiple myeloma: routes to diagnosis, clinical characteristics and survival – findings from a UK population‐based study
por: Howell, Debra, et al.
Publicado: (2017)

Perspectives of bereaved relatives of patients with haematological malignancies concerning preferred place of care and death: A qualitative study
por: McCaughan, Dorothy, et al.
Publicado: (2019)

Disease-related factors affecting timely lymphoma diagnosis: a qualitative study exploring patient experiences
por: Howell, Debra A, et al.
Publicado: (2019)

Preferred and actual place of death in haematological malignancy
por: Howell, D A, et al.
Publicado: (2017)

Germ-Line Transmitted, Chromosomally Integrated HHV-6 and Classical Hodgkin Lymphoma
por: Bell, Adam J., et al.
Publicado: (2014)

Estimating the prevalence of hematological malignancies and precursor conditions using data from Haematological Malignancy Research Network (HMRN)
por: Li, Jinlei, et al.
Publicado: (2016)

Cohort profile: the United Kingdom Childhood Cancer Study (UKCCS) – a UK-wide population-based study examining the health of cancer survivors
por: Roman, Eve, et al.
Publicado: (2023)

Constitutive overexpression of a novel 21 kDa protein by Hodgkin Lymphoma and Aggressive Non-Hodgkin Lymphomas
por: Zhou, Minglong, et al.
Publicado: (2008)

The Benefit of Telemonitoring in the Prevention of Septic Shock in a Patient with Aggressive Non-Hodgkin’s Lymphoma
por: Dudová, Lucie, et al.
Publicado: (2023)

Myeloma: Patient accounts of their pathways to diagnosis
por: Howell, Debra A., et al.
Publicado: (2018)

Hodgkin’s lymphoma is a rare form of clonal haematological non-mast cell disease in systemic mastocytosis
por: Gasljevic, Gorana, et al.
Publicado: (2015)

Excess morbidity and mortality among survivors of childhood acute lymphoblastic leukaemia: 25 years of follow-up from the United Kingdom Childhood Cancer Study (UKCCS) population-based matched cohort
por: Kane, Eleanor, et al.
Publicado: (2022)

Rasburicase-Induced Methemoglobinemia in a Patient with Aggressive Non-Hodgkin’s Lymphoma
por: Alessa, Mohammed A., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_3t5idbjnq9nd38neuokrc3u9cj